Variant report

Variant	nsv435913
Chromosome Location	chr10:6410196-6417665
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr10:6359485..6361355-chr10:6417386..6419861,2	MCF-7	breast:
2	chr10:6409324..6412633-chr10:6424291..6427904,3	MCF-7	breast:
3	chr10:6244747..6246248-chr10:6416212..6418956,2	MCF-7	breast:
4	chr10:6409518..6411373-chr10:6428852..6430851,2	MCF-7	breast:

Variant related genes	Relation type
ENSG00000170525	chromatin interactions

Extended variants
information (count: 93 )
Associated
traits (count: 55 )

Variant overlapped rSNPs/rCNVs (count:93 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs541297312	chr10:6410196-6410197	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs188002162	chr10:6410246-6410247	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs148942637	chr10:6410262-6410263	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs548653848	chr10:6410289-6410290	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs192566387	chr10:6410343-6410344	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs569772630	chr10:6410356-6410357	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs547170845	chr10:6410360-6410361	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs182256363	chr10:6410405-6410406	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs186964227	chr10:6410415-6410416	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs143721377	chr10:6410446-6410447	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs192442077	chr10:6410458-6410459	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs57110059	chr10:6410468-6410469	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs549786711	chr10:6410486-6410487	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs148077743	chr10:6410493-6410494	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs141856671	chr10:6410518-6410519	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs185035930	chr10:6410519-6410520	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs547533541	chr10:6410531-6410532	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs576181082	chr10:6410541-6410542	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs543461036	chr10:6410578-6410579	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs146897495	chr10:6410703-6410704	Weak transcription Bivalent/Poised TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs565791024	chr10:6410716-6410717	Weak transcription Bivalent/Poised TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs79561420	chr10:6410733-6410734	Weak transcription Bivalent/Poised TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs559735234	chr10:6410752-6410753	Weak transcription Bivalent/Poised TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs369219681	chr10:6410791-6410792	Weak transcription Bivalent/Poised TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs190104969	chr10:6410811-6410812	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs542010161	chr10:6410812-6410813	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs563463233	chr10:6410861-6410862	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs192945396	chr10:6410905-6410906	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs530875543	chr10:6410930-6410931	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs552184154	chr10:6410935-6410936	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs570488725	chr10:6410937-6410938	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs532347920	chr10:6410980-6410981	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs112649491	chr10:6410991-6410992	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs184690605	chr10:6411008-6411009	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs189605145	chr10:6411018-6411019	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs568787955	chr10:6411043-6411044	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs10906351	chr10:6411071-6411072	Weak transcription Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs537122159	chr10:6411081-6411082	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs10796061	chr10:6411109-6411110	Weak transcription Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs537774343	chr10:6411121-6411122	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs534280759	chr10:6411201-6411202	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs553631179	chr10:6411205-6411206	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs116332510	chr10:6411215-6411216	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs78805750	chr10:6411243-6411244	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs77521284	chr10:6411246-6411247	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs575359684	chr10:6411270-6411271	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs143198356	chr10:6411303-6411304	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs4750347	chr10:6411327-6411328	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs373443167	chr10:6411430-6411431	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs535225603	chr10:6411441-6411442	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:55)

Disease	PMID	Source
Sudden cardiac death	19188705	CNVD
Digeorge syndrome	22283845	CNVD
Cancer	21129771	CNVD
Colorectal cancer	20709793	CNVD
Wilms tumour	19047088	CNVD
Hepatocellular carcinoma	16750200	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21183584	CNVD
Barakat syndrome	22470819	CNVD
Melanoma	18172304	CNVD
Ovarian cancer	21720365	CNVD
Autism	18414403	CNVD
Malignant melanoma	18718029	CNVD
Breast cancer	22032731	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Glioblastoma multiforme	21080181	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Phyllodes tumor	17334353	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Thoracic aortic aneurysm	21092924	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ewing''s sarcoma	17952124	CNVD
Oral cancer	21386901	CNVD
Breast cancer	21785460	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
Renal cell carcinoma	18765545	CNVD
lymphocytic leukemia	21291569	CNVD
Urothelial cell carcinoma	18451213	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Myxofibrosarcoma	16751306	CNVD
Non-muscle invasive bladder neoplasm	19445696	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:22 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:6396800-6410800	Weak transcription	Aorta	Aorta
2	chr10:6403400-6410200	Weak transcription	Ovary	ovary
3	chr10:6407000-6410400	Enhancers	H9 Cell Line	embryonic stem cell
4	chr10:6407400-6422000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
5	chr10:6409200-6411600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
6	chr10:6409400-6410800	Weak transcription	H1 Cell Line	embryonic stem cell
7	chr10:6409800-6410400	Enhancers	ES-I3 Cell Line	embryonic stem cell
8	chr10:6409800-6410600	Enhancers	Primary neutrophils fromperipheralblood	blood
9	chr10:6410000-6410200	Enhancers	HUES6 Cell Line	embryonic stem cell
10	chr10:6410000-6410200	Enhancers	iPS-20b Cell Line	embryonic stem cell
11	chr10:6410000-6410400	Enhancers	HUES48 Cell Line	embryonic stem cell
12	chr10:6410200-6410400	Enhancers	Ovary	ovary
13	chr10:6410200-6411000	Enhancers	Right Atrium	heart
14	chr10:6410600-6410800	Bivalent/Poised TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
15	chr10:6410600-6411000	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
16	chr10:6410600-6411000	Active TSS	Stomach Smooth Muscle	stomach
17	chr10:6410600-6411200	Active TSS	Muscle Satellite Cultured Cells	--
18	chr10:6410600-6421000	Weak transcription	Primary neutrophils fromperipheralblood	blood
19	chr10:6410800-6411000	Enhancers	Aorta	Aorta
20	chr10:6410800-6411200	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
21	chr10:6411000-6423800	Weak transcription	Aorta	Aorta
22	chr10:6417400-6421400	Weak transcription	Brain Hippocampus Middle	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links